Amazon lists one requirement in the stunning request for proposals it issued Thursday, which invites cities across North America to compete to host a second corporate headquarters for the tech and commerce giant. Economic development officials are justifiably salivating at the once-in-a-generation opportunity to attract what is arguably the 21st century’s most important company, and … Continue reading “To Win Amazon’s HQ2, Incentives Are Nice, But Talent Is Required”
Category: Detroit
Fireside Chat with Duo Security’s Dug Song
Startup Grind hosts this event featuring Xconomist Dug Song, co-founder and CEO of Duo Security, one of Michigan’s fastest-growing tech companies. Xconomy readers can get 5o percent off admission by using the code Xconomy50OFF. For more information, click here.
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More
The summer doldrums are over. Biotech news came at a breakneck pace this week both before and after Labor Day, starting with the surprise resignation of Novartis’s top executive just days after the Swiss company notched an historic FDA approval. From there, the week featured big headlines, both good and bad, from several trials in … Continue reading “Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More”
Five Regions That Could Draw Amazon’s Next Headquarters
[Updated 4:26 p.m. See below.] Amazon sent cities across North America into a frenzy Thursday after announcing plans to build a second headquarters outside of Seattle, bringing with it tens of thousands of jobs and billions of dollars in economic development benefits. The tech and commerce giant says it wants cities and states to apply … Continue reading “Five Regions That Could Draw Amazon’s Next Headquarters”
Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA
Biotech CEOs Jeremy Levin and Steve Holtzman are continuing their recent push to spur the life sciences industry to speak out against government policies it doesn’t agree with. Levin, CEO of Ovid Therapeutics (NASDAQ: [[ticker:OVID]]) and Holtzman, the head of Decibel Therapeutics, co-authored a letter to the Trump administration and congressional leaders asking them to … Continue reading “Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA”
Lasker Award Goes to HPV Vaccine Developers Lowy, Schiller
A top prize in American biomedical science was awarded today to two scientists for their discoveries that led to the development of a human papillomavirus (HPV) vaccine, which prevents cervical cancer caused by the sexually transmitted virus. Douglas Lowy (pictured right), acting director of the National Cancer Institute (NCI), and John Schiller (left), also at … Continue reading “Lasker Award Goes to HPV Vaccine Developers Lowy, Schiller”
Sahi Cosmetics Offers Science-Backed Products for Olive Skin Tones
Shelly Sahi, founder and CEO of Sahi Cosmetics, thought she wanted to be a doctor. It wasn’t until she finished her undergraduate studies at the University of Michigan that she realized how burnt out she was—and that a career in the medical field was actually her parents’ dream, not hers. “I discovered entrepreneurship later because … Continue reading “Sahi Cosmetics Offers Science-Backed Products for Olive Skin Tones”
U-M Life Sci Institute Looks Ahead with $150M Initiative, Symposium
The University of Michigan’s Life Sciences Institute (LSI) is hosting its 16th annual Saltiel Life Sciences Symposium later this month, and for the first time, rather than focusing on a narrow segment of the industry, the lineup of speakers will discuss the technologies behind some of the sector’s most exciting recent innovations. “Alan [Saltiel] started … Continue reading “U-M Life Sci Institute Looks Ahead with $150M Initiative, Symposium”
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More
[Corrected 9/5/17, 12:22 p.m. See below.] The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9 billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. It’s one of … Continue reading “Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More”
Novartis: CAR-T Results In One Month, Or No Charge. Why One Month?
Novartis said Wednesday that it would not charge for its newly approved cellular immunotherapy, tisagenlecleucel (Kymriah)—the first so-called CAR-T product to ever come to market—if it fails to help patients within a month. If the cell therapy, approved for kids with leukemia who have run out of other options, starts to work within a month, … Continue reading “Novartis: CAR-T Results In One Month, Or No Charge. Why One Month?”
NYT on Neurable’s Brain-Controlled Virtual Reality Game: It Works
When Neurable first popped up on Xconomy’s radar in late 2015, it was a small, mostly student-led University of Michigan spinout working on cutting-edge brain-computer interface innovations that would allow people to control software using only their thoughts. Back then, it sounded exciting yet fairly far out. However, a lot has changed since. Today, Neurable is … Continue reading “NYT on Neurable’s Brain-Controlled Virtual Reality Game: It Works”
Embracing the Inevitable Changes of Self-Driving Vehicles
Read today’s news and you’d think fully autonomous vehicles—commercial vehicles, in particular—will be everywhere in the very near future. With headlines like these, it’s no wonder: Self-Driving Trucks Could be on Highways in 3 to 4 Years U.S. and Europe Race to be First to Self-Driving Trucks Ford Plans Self-Driving Car for Ride Share Fleets … Continue reading “Embracing the Inevitable Changes of Self-Driving Vehicles”
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Ahead of schedule, Novartis has received the first-ever approval of a genetically modified living cell therapy called CAR-T, which uses a cancer patient’s own immune cells as the medicine. Within days, children and young adults with a severe form of acute lymphoblastic leukemia could receive the treatment at a handful of centers across the U.S. … Continue reading “Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000”
GoKid App Helps Busy Parents Connect and Share Carpooling Duties
GoKid, the carpooling app startup that went through the Techstars Mobility accelerator program in Detroit last summer, today unveiled a new enterprise version of its product for schools called GoKid Connect. Based in the Motor City and New York City, GoKid is a mobile tool that allows parents to create and manage carpooling schedules. Parents … Continue reading “GoKid App Helps Busy Parents Connect and Share Carpooling Duties”
Taking Tech Ideas Global: Connecting an Innovation Ecosystem
The word ecosystem conjures up a rain forest in Ecuador, where sunlight, soil, water, and a multitude of species exist together in a self-sustaining environment that is constantly evolving. This image from biology translates perfectly into what many people like to call an innovation ecosystem. Think of a group of people developing a new idea, … Continue reading “Taking Tech Ideas Global: Connecting an Innovation Ecosystem”
Who is Dara Khosrowshahi, Uber’s Pick to be CEO?
The news broke Sunday night that Uber has offered the job of CEO to Dara Khosrowshahi, the outspoken steady hand guiding Bellevue, WA-based online travel giant Expedia (NASDAQ: [[ticker:EXPE]]) for the last dozen years. Khosrowshahi and Uber have not officially confirmed the news as of Monday evening. An internal e-mail from Barry Diller, Expedia chairman, … Continue reading “Who is Dara Khosrowshahi, Uber’s Pick to be CEO?”
LinkedIn Opens Downtown Detroit Office, Starts Search for Employees
It never fails: Every time we briefly close the Xconomy Detroit/Ann Arbor office to take a vacation, an important piece of local tech news hits. This time around, LinkedIn, the social media site primarily used for professional networking and resume-sharing, announced it is opening a Detroit office—the company’s first new office in 10 years. Last … Continue reading “LinkedIn Opens Downtown Detroit Office, Starts Search for Employees”
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists
It’s clear at this point that patients are no longer just subjects in clinical trials. Thanks to the growing power of patient advocacy groups—and an FDA eager to hear their perspective—patients and drug developers are increasingly finding creating ways to work together, as we’ve seen with the four finalists in the Patient Partnership category of … Continue reading “Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists”
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand
In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience. The totality of the solar eclipse lasted less than 3 minutes. If you missed it, you’ll have to wait until 2024 for the next one. … Continue reading “Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand”
Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers
Biotech CEOs Jeremy Levin and Steve Holtzman have watched the violence in Charlottesville, VA, and its continuing aftermath with disgust. But they aren’t just upset about the rally, the violence and death, and President Trump’s equivocating blame of “many sides.” Levin, of Ovid Therapeutics (NASDAQ: [[ticker:OVID]]), and Holtzman, of Decibel Therapeutics, have been disappointed with … Continue reading “Stand Up to “Bully” Trump: Bio CEOs Levin, Holtzman Call to Their Peers”
The Downside of Immersive Tech: An Increasingly Isolated World
As an entrepreneur who has been involved in tech and media for over two decades, I have seen my share of disruptions (I so hate that word!) and even participated in a few. Back in the 1990s, while we were developing some broadband technologies at Sourcecom, my first startup, we also had to develop the … Continue reading “The Downside of Immersive Tech: An Increasingly Isolated World”
After Y Combinator, May Mobility Ready to Test Self-Driving Fleets
[Corrected, 10:16 am. See below] There has been a lot of speculation about what Ann Arbor, MI-based May Mobility has been up to since the company began working in stealth mode early this year. The new company has to do with autonomous vehicles—one of the hottest fields in tech—but until this week its website revealed … Continue reading “After Y Combinator, May Mobility Ready to Test Self-Driving Fleets”
On Drug Pricing: FDA Backs Up Its Calls for Increased Competition
FDA Commissioner Scott Gottlieb has been very public in expressing his desire to provide increased competition and greater choice to American consumers in a bid to drive down prices of prescription medicines. Recently, the agency he oversees took some unusual steps to back up those statements with action. Last week, the FDA approved the use … Continue reading “On Drug Pricing: FDA Backs Up Its Calls for Increased Competition”
Roundup: Grand Circus, STEM Initiatives, and a Lot of Cybersecurity
—Grand Circus, the coding school with campuses in downtown Detroit and Grand Rapids, is partnering with Facebook to offer a front-end developer bootcamp in October. The training course will combine Grand Circus’ front-end curriculum with React, an open-source JavaScript platform. Successful applicants will receive full scholarships and training in HTML5/CSS3, JavaSript, jQuery, React, Node.js, NPM, AJAX, … Continue reading “Roundup: Grand Circus, STEM Initiatives, and a Lot of Cybersecurity”
Nvidia Joins $20M Deal in Chinese Self-Driving Startup TuSimple
Nvidia (NASDAQ: [[ticker:NVDA]]), the Santa Clara, CA-based maker of specialized graphics processing chips that have become workhorses in artificial intelligence, has joined a group of investors that put $20 million into TuSimple, a Chinese startup developing self-driving technology for long-haul trucks. In a blog posted Wednesday, Nvidia says TuSimple has used Nvidia GPUs, the Nvidia … Continue reading “Nvidia Joins $20M Deal in Chinese Self-Driving Startup TuSimple”
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More
The CEO of a major U.S. pharmaceutical company was in the news this week, but for a change not because of the cost of drugs. Merck CEO Kenneth Frazier (pictured) was the first of what quickly became a line of CEOs to exit President Trump’s manufacturing council, leading to its dissolution altogether. Frazier was widely … Continue reading “Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More”
Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists
The finalists in the Young Innovator category of the 2017 Xconomy Awards show that it’s never too early in life to start a company or invent a new technology. These four individuals (30 years of age or under) share a strong drive, even a restlessness, to build new things that make a difference. Three knew … Continue reading “Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists”
U-M Impact Challenge Students Collaborate with Detroit Entrepreneurs
The University of Michigan’s Ross School of Business is a proponent of action-based learning, and of business being a force for positive change in the world. Those two philosophies combine this week for U-M’s annual Impact Challenge, where all 422 incoming graduate students spend four days in Detroit collaborating with local entrepreneurs. Organized by U-M’s … Continue reading “U-M Impact Challenge Students Collaborate with Detroit Entrepreneurs”
Private Equity Investors Have $740 Billion to Spend, Driving Valuations
Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. As of Aug. 1, private equity firms in North America and Europe had secured $212.6 billion in new commitments this year, on pace to eclipse the “already stellar” fundraising … Continue reading “Private Equity Investors Have $740 Billion to Spend, Driving Valuations”
120WaterAudit Brings Data Visualization to Contaminant Testing
In most of America, people expect clean, drinkable water to pour from the tap. However, there are deep cracks emerging in the nation’s aging water infrastructure, and the Trump administration’s Environment Protection Agency has been quietly working to “roll back” clean water protections in favor of industry priorities. Municipalities with tight budgets risk making disastrous … Continue reading “120WaterAudit Brings Data Visualization to Contaminant Testing”
PARC Spinout Metawave Adds A.I. to Metamaterials for Autonomous Cars
A serial entrepreneur in the field of metamaterials is building a new company to develop the technology for use in autonomous vehicles and wireless communications. Maha Achour co-founded Metawave early this year, spinning the company out of the storied PARC laboratories, a unit of Xerox, in Palo Alto, CA, with an exclusive license to commercialize … Continue reading “PARC Spinout Metawave Adds A.I. to Metamaterials for Autonomous Cars”
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists
Startups play a critical role in the innovation economy that we chronicle at Xconomy—transforming new ideas that begin in a lab into the products and companies of tomorrow. No surprise, then, that the startup category in our first-ever Awards program was a particularly competitive one, loaded with private companies (no more than 5 years old) … Continue reading “Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists”
Genesis Innovation Raises $1.1M to Invest in Medical Device Startups
Holland, MI-based Genesis Innovation Group announced early this month that it has raised $1.1 million in capital to invest in new medical device technologies. Since its 2013 inception, Genesis has raised a total of $2.3 million. Genesis is not a traditional venture capital firm, says co-founder and CEO Rob Ball. Instead, it’s a consulting group … Continue reading “Genesis Innovation Raises $1.1M to Invest in Medical Device Startups”
Angel Investor Workshop
Startup Angels and Techstars Mobility will host an investor workshop ahead of the Techstars Mobility program’s annual demo day event on Oct. 18. The purpose of the workshop is to share best practices and the latest methodologies with aspiring local angel investors and refine their knowledge, skills, and resources. For registration, click here.
Kauffman Fellows Take On VC Sexual Harassment, Bench Mentor McClure
If you’re looking for a counterpoint to the recent flurry of news stories about sexual harassment and gender bias in the tech sector, the Kauffman Fellows program isn’t a bad place to start. The Palo Alto, CA-based program, a spinoff of the Ewing Marion Kauffman Foundation, has been a gateway into the venture capital industry … Continue reading “Kauffman Fellows Take On VC Sexual Harassment, Bench Mentor McClure”
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More
With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital. The FDA reported that generic drug approvals are set to hit a record; the agency under Commissioner Scott … Continue reading “Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More”
Tech Hiring Trends: Buzzwords, Trump Effect, and Gender-Pay Gap
As the tech economy continues its historic boom, here’s three views of labor market trends released this week, including the rise and fall of buzzwords in engineering job postings; the Trump Administration’s impact on U.S. companies’ interest in foreign workers; and another disappointing look at the gender-pay gap. —In the last two years, big data … Continue reading “Tech Hiring Trends: Buzzwords, Trump Effect, and Gender-Pay Gap”
Care Convene Aims to Make Telemedicine as User-Friendly as Facebook
Jefferey VanWingen is a family doctor who has been practicing medicine for 17 years. Although he’s based in Grand Rapids, MI, he’s also been taking medical missions to India for the past decade. It’s always been his goal to use technology to bridge his physical distance from the Wi-Fi-enabled community he works with in India. … Continue reading “Care Convene Aims to Make Telemedicine as User-Friendly as Facebook”
Why We All Should Care About the Recent Brouhaha at Google
The issues raised by the 10-page memo on the suitability of women for certain engineering and leadership positions at Google (culminating in the firing of its author) have implications for all of us. They are as much about the requirements for success in today’s workplace—and how to identify and nurture those qualities in all employees—as they … Continue reading “Why We All Should Care About the Recent Brouhaha at Google”
Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists
There are many ways to stand out as a biotech CEO, from getting a company started in the first place to pushing its first drug over the finish line. Those differences are what we noticed when going through the nominations from you, the readers, for the top Boston biotech CEO, as part of the first-ever … Continue reading “Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists”
MTRAC Program Helps Early-Stage Automotive Technology Get to Market
With the era of the autonomous vehicle dawning, the technologies required to develop driverless cars have never been hotter. But before they hit the marketplace, cutting-edge innovations often necessitate a lot of research, and much of that early research is conducted in an academic setting. The Michigan Translational Research and Commercialization (MTRAC) program for advanced … Continue reading “MTRAC Program Helps Early-Stage Automotive Technology Get to Market”
Xconomy Awards: The Finalists Are….
The nominees for our first ever Xconomy Awards were an impressive bunch, and represent a wide range of the technologies, approaches, and yes, personalities, that are all driving Boston biotech today. There’s a lot of talent in this town, so narrowing the list of more than 250 nominations down to a handful of finalists in … Continue reading “Xconomy Awards: The Finalists Are….”
An Insider’s Guide to Bridging the Biotech Gender Gap
As an executive recruiter focused solely on life sciences, I’m among the first to acknowledge the industry’s gender gap. Of the 20 largest pharmaceutical companies around the world, only one has a woman at the helm—and GSK named Emma Natasha Walmsley as CEO less than five months ago. Among biotech executive leadership teams, women make … Continue reading “An Insider’s Guide to Bridging the Biotech Gender Gap”
Neurable’s Brain-Computer Interface Platform Scores U-M Investment
Neurable, a University of Michigan spinout now located in Cambridge, MA, has received a new investment from the university’s Zell Lurie Founders Fund to help commercialize its brain-computer interface (BCI) technology. The amount of the investment was not disclosed. The new capital builds on a $2 million seed round the company raised last December, says … Continue reading “Neurable’s Brain-Computer Interface Platform Scores U-M Investment”
With $5M Investment, Toyota Is First Auto Co. to Back Mobility Center
As news reports this morning say that Toyota and Mazda are planning to open a new $1.6 billion U.S. manufacturing plant—location to be determined—Toyota is also making moves in Michigan. This week, the American Center for Mobility (ACM) announced that the Japanese automotive company has ponied up $5 million to be a founding sponsor of the autonomous vehicle … Continue reading “With $5M Investment, Toyota Is First Auto Co. to Back Mobility Center”
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More
Gene editing took an important step this week when a group of U.S. researchers used CRISPR-Cas9 technology to correct a genetic error in dozens of human embryos without complications. It’s a significant achievement, but amidst the hype, it’s worth cautioning just how much work has to be done before the technology leads to a safe … Continue reading “Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More”
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: [[ticker:BMY]]) will pay $300 million up front for IFM, which will give … Continue reading “IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout”
Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead?
In an environment of microscopic interest rates, it is particularly interesting to read the Preqin 2Q17 Quarterly Update, which exhaustively tracks all things private equity and venture capital. At the end of June 2017 there were 1,998 funds in market raising a total of $676 billion – a staggering sum – indicative of global investors … Continue reading “Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead?”
Clinc’s A.I. Lets USAA Members Casually Chat with Their Bank Accounts
Ever wanted to casually talk to your bank account and find out how much money you have in checking, or what your restaurant spending looked like a year ago? If you’re a member of USAA, the financial institution serving members of the U.S. military, and have an Amazon Alexa device, now you can. Clinc, the … Continue reading “Clinc’s A.I. Lets USAA Members Casually Chat with Their Bank Accounts”
MVCA Report Shines Light on Detroit’s Startup Growth and Challenges
For roughly the past five years, Detroit’s tech startup ecosystem has been growing at a rapid pace. However, accounts have differed as to just how much growth has occurred. A recent report by the Michigan Venture Capital Association (MVCA) attempts to shine a light on the subject while detailing a couple of key findings. According … Continue reading “MVCA Report Shines Light on Detroit’s Startup Growth and Challenges”